GLPwatch
Bydureon
exenatide · astrazeneca
Last updated 2026-05-28Bydureon contains the active ingredient exenatide and is made by AstraZeneca; it is given as a once-weekly injection under the skin. The FDA has approved it to improve blood sugar levels in adults with type 2 diabetes. The label warns that Bydureon may increase the risk of thyroid tumors, including cancer, based on studies in rats.
AI summary of the sources below.
| Active ingredient | exenatide |
|---|---|
| Manufacturer | astrazeneca |
| Route | subcutaneous injection |
| Approved indications | type-2-diabetes |
How Bydureon connects
- Molecule exenatide
- Treats Type 2 diabetes
- Side effects NauseaInjection site reactionVomiting
- Research 899 papers
- Maker AstraZeneca
- Trials 207 trials
Top reported side effects
FAERS voluntary-report counts (2026Q1) — not incidence or causation.
Common questions
- What is Bydureon?
- Bydureon contains the active ingredient exenatide and is made by AstraZeneca; it is given as a once-weekly injection under the skin. The FDA has approved it to improve blood sugar levels in adults with type 2 diabetes. The label warns that Bydureon may increase the risk of thyroid tumors, including cancer, based on studies in rats.
- What is Bydureon approved to treat?
- Bydureon is FDA-approved to treat type 2 diabetes.
- Is there a shortage of Bydureon right now?
- We have no current FDA shortage record for exenatide (the active ingredient in Bydureon).
- What are the most-reported side effects of Bydureon?
- The most-reported adverse events for Bydureon in the FDA's FAERS database are nausea, injection site reaction and vomiting. FAERS counts reflect voluntary reports and do not show how often a side effect actually occurs.
- How is Bydureon taken?
- Bydureon is given by subcutaneous injection.
- Who makes Bydureon?
- Bydureon is made by Astrazeneca.